<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f1 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f2 { font-family:ff0,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f3 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f4 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f5 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
#f6 { font-family:ff8,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff9; src: url("9.ttf"); }
#f7 { font-family:ff9,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff10; src: url("10.ttf"); }
#f8 { font-family:ff10,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff11; src: url("11.ttf"); }
#f9 { font-family:ff11,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="841" src="page2.png">
<div class="txt" style="position:absolute; left:486px; top:54px;"><span id="f2" style="font-size:8px;vertical-align:baseline;color:rgba(255,255,255,1);">SK(034730)</span></div>
<div class="txt" style="position:absolute; left:191px; top:106px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">2020</span><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">년 글로벌 종합 바이오제약사로 도약</span></div>
<div class="txt" style="position:absolute; left:191px; top:124px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2020</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 글로벌 종합바이오제약사로 신약 및 의약 중간체를 연구개발하고</span></div>
<div class="txt" style="position:absolute; left:191px; top:140px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">판매하는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">국내</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽 생산을 맡는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오텍</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">미국 생산을 맡는</span></div>
<div class="txt" style="position:absolute; left:191px; top:156px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">AMPAC</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">을 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">100% </span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">자회사로 거느린 사업 구조를 갖췄다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. SK</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜이 개발한</span></div>
<div class="txt" style="position:absolute; left:191px; top:172px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">뇌전증 치료제 세노바메이트는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">상 마지막 단계로 연내 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">FDA </span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">신약승인신청</span></div>
<div class="txt" style="position:absolute; left:191px; top:188px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(NDA)</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">을 할 계획이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">뇌전증 치료제 시장 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">위인 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Vimpat</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 실적을 고려 시</span></div>
<div class="txt" style="position:absolute; left:191px; top:204px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">는 세노바메이트의 연간 매출을 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조원 수준으로 기대 중이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">신약승인이 마</span></div>
<div class="txt" style="position:absolute; left:191px; top:220px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">무리되면 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">AMPAC</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 미국 생산 시설을 통해서 현지 생산</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">판매가 가능할 것으로</span></div>
<div class="txt" style="position:absolute; left:191px; top:236px;"><span id="f5" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">예상되기에 자회사간 시너지에서도 긍정적이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:191px; top:267px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;</span><span id="f4" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">표 </span><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">1&gt; SK </span><span id="f4" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">글로벌 투자 현황</span></div>
<div class="txt" style="position:absolute; left:191px; top:296px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2017 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">월</span></div>
<div class="txt" style="position:absolute; left:226px; top:307px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">월</span></div>
<div class="txt" style="position:absolute; left:226px; top:319px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">7</span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">월</span></div>
<div class="txt" style="position:absolute; left:191px; top:341px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2018 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">3 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">월</span></div>
<div class="txt" style="position:absolute; left:226px; top:353px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">5</span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">월</span></div>
<div class="txt" style="position:absolute; left:226px; top:364px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">7</span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">월</span></div>
<div class="txt" style="position:absolute; left:255px; top:285px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">주요내용</span></div>
<div class="txt" style="position:absolute; left:255px; top:296px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">LG </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">실트론 지분 </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">51% </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">인수</span></div>
<div class="txt" style="position:absolute; left:255px; top:307px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">아일랜드 </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">BMS </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">원료 의약품 생산 공장 인수</span></div>
<div class="txt" style="position:absolute; left:255px; top:319px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">중국 물류 사업 회사 </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">ESR </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">지분 </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">11.77% </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">투자</span></div>
<div class="txt" style="position:absolute; left:255px; top:330px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SK </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">차이나 유상증자 참여</span></div>
<div class="txt" style="position:absolute; left:255px; top:341px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SK </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜 유상증자 참여</span></div>
<div class="txt" style="position:absolute; left:255px; top:353px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국 셰일원유</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">가스 회사 브라조스 투자</span></div>
<div class="txt" style="position:absolute; left:255px; top:364px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국 의약품 생산 기업 </span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">AMPAC </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">인수</span></div>
<div class="txt" style="position:absolute; left:191px; top:378px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">언론보도</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:426px; top:285px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">투자규모</span></div>
<div class="txt" style="position:absolute; left:426px; top:296px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6,200 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span></div>
<div class="txt" style="position:absolute; left:426px; top:307px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,700 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span></div>
<div class="txt" style="position:absolute; left:426px; top:319px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">3,720 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span></div>
<div class="txt" style="position:absolute; left:426px; top:330px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2,600 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span></div>
<div class="txt" style="position:absolute; left:426px; top:341px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,500 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span></div>
<div class="txt" style="position:absolute; left:426px; top:353px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2,700 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span></div>
<div class="txt" style="position:absolute; left:426px; top:364px;"><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">7,000 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">~8,000 </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">억원으로 추산</span></div>
<div class="txt" style="position:absolute; left:58px; top:412px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">[</span><span id="f4" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">그림 </span><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">1] SK</span><span id="f4" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">의 원료의약품 사업 타임라인</span></div>
<div class="txt" style="position:absolute; left:349px; top:431px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">2017: </span><span id="f8" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">확장</span></div>
<div class="txt" style="position:absolute; left:349px; top:441px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- </span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">세종 </span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">공장 증설</span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">명학산단</span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:349px; top:450px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- BMS Ireland Swords </span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">공장 인수</span></div>
<div class="txt" style="position:absolute; left:349px; top:459px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">8</span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">월 </span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">미국 </span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">CDMO </span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">기업 </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">AMPAC </span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">인수</span></div>
<div class="txt" style="position:absolute; left:359px; top:475px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">2016: </span><span id="f8" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">지배구조 변경</span></div>
<div class="txt" style="position:absolute; left:359px; top:485px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- SK</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">㈜의 직접 </span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">자회사로 전환</span></div>
<div class="txt" style="position:absolute; left:318px; top:506px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">2015: SK</span><span id="f8" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">바이오텍 분사</span></div>
<div class="txt" style="position:absolute; left:318px; top:516px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜 </span><span id="f7" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">CMS </span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">사업부 물적분할</span></div>
<div class="txt" style="position:absolute; left:63px; top:545px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">1998: </span><span id="f8" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">의약품 생산 사업 진출</span></div>
<div class="txt" style="position:absolute; left:63px; top:555px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- </span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">화학</span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">/</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">촉매기술 기반 아래 사업화</span></div>
<div class="txt" style="position:absolute; left:74px; top:564px;"><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">모색</span></div>
<div class="txt" style="position:absolute; left:63px; top:573px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- </span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">의약품 생산사업 개시</span></div>
<div class="txt" style="position:absolute; left:63px; top:582px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(255,255,255,1);">- </span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">&gt; 1999</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">공장 생산 시작</span></div>
<div class="txt" style="position:absolute; left:63px; top:590px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(255,255,255,1);">- </span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">&gt; 2003</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2,3</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">공장 생산 시작</span></div>
<div class="txt" style="position:absolute; left:302px; top:536px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">2013: </span><span id="f8" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">원료의약품 사업 확대</span></div>
<div class="txt" style="position:absolute; left:302px; top:546px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- </span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">각국 </span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">규제기관 인증 확보</span></div>
<div class="txt" style="position:absolute; left:302px; top:555px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(255,255,255,1);">- </span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">&gt; </span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">일본</span><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">(2013)</span></div>
<div class="txt" style="position:absolute; left:190px; top:564px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">2005: </span><span id="f8" style="font-size:8px;vertical-align:baseline;color:rgba(85,146,206,1);">원료의약품 사업 진출 </span><span id="f6" style="font-size:7px;vertical-align:super;color:rgba(255,255,255,1);">- </span><span id="f6" style="font-size:7px;vertical-align:super;color:rgba(0,0,0,1);">&gt; </span><span id="f9" style="font-size:7px;vertical-align:super;color:rgba(0,0,0,1);">미국</span><span id="f6" style="font-size:7px;vertical-align:super;color:rgba(0,0,0,1);">(2014)</span></div>
<div class="txt" style="position:absolute; left:190px; top:572px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">- BMS</span><span id="f9" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">사 </span><span id="f8" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">당뇨치료제 첫 수주 </span><span id="f6" style="font-size:7px;vertical-align:super;color:rgba(255,255,255,1);">- </span><span id="f6" style="font-size:7px;vertical-align:super;color:rgba(0,0,0,1);">&gt; </span><span id="f9" style="font-size:7px;vertical-align:super;color:rgba(0,0,0,1);">유럽</span><span id="f6" style="font-size:7px;vertical-align:super;color:rgba(0,0,0,1);">(2015)</span></div>
<div class="txt" style="position:absolute; left:68px; top:623px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1990</span></div>
<div class="txt" style="position:absolute; left:215px; top:623px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2000</span></div>
<div class="txt" style="position:absolute; left:361px; top:623px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2010</span></div>
<div class="txt" style="position:absolute; left:513px; top:623px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2020</span></div>
<div class="txt" style="position:absolute; left:75px; top:642px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">23</span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">개 고객사</span></div>
<div class="txt" style="position:absolute; left:75px; top:654px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">40</span><span id="f9" style="font-size:9px;vertical-align:baseline;color:rgba(255,255,255,1);">개 제품생산</span></div>
<div class="txt" style="position:absolute; left:170px; top:647px;"><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">2017</span><span id="f8" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">년 연간 매출 </span><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">1,094</span><span id="f8" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">억</span><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">, </span><span id="f8" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">영업이익 </span><span id="f7" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">285</span><span id="f8" style="font-size:12px;vertical-align:baseline;color:rgba(255,255,255,1);">억</span></div>
<div class="txt" style="position:absolute; left:56px; top:701px;"><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">언론보도</span><span id="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:533px; top:795px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(128,128,128,1);">2</span></div>
</body>
</html>
